dimyristoylphosphatidylcholine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armes, SP; Avila-Olias, M; Battaglia, G; Canton, I; Cecchin, D; Colley, HE; Hearnden, V; Hu, K; MacNeil, S; Madsen, J; McKeating, JA; Murdoch, C; Thornhill, MH; Warren, N | 1 |
1 other study(ies) available for dimyristoylphosphatidylcholine and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Dimyristoylphosphatidylcholine; Doxorubicin; Drug Delivery Systems; Head and Neck Neoplasms; Humans; Hydrogen-Ion Concentration; Paclitaxel; Polymethacrylic Acids; Squamous Cell Carcinoma of Head and Neck | 2014 |